tm
Seeing Is Believing
tm
Seeing Is Believing
VYNE is currently covered by 2 analysts with an average price target of $44.02. This is a potential upside of $42.65 (3113.14%) from yesterday's end of day stock price of $1.37.
Vyne Therapeutics's activity chart (see below) currently has 13 price targets and 34 ratings on display. The stock rating distribution of VYNE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 29.71% with an average time for these price targets to be met of 400.33 days.
Highest price target for VYNE is $4.5, Lowest price target is $4.5, average price target is $6.75.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 25-Apr-2025. First documented stock forecast 06-Sep-2018.
Currently out of the existing stock ratings of VYNE, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4.5
$3.07 (214.69%)
$5.75
7 days ago
(25-Apr-2025)
3/19 (15.79%)
$3.07 (214.69%)
825
Buy
$9
$7.57 (529.37%)
1 years 11 months 20 days ago
(12-May-2023)
1/3 (33.33%)
$1.77 (24.48%)
346
Buy
2 years 8 months 22 days ago
(10-Aug-2022)
2/5 (40%)
$123.12 (95.53%)
30
What is VYNE (Vyne Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on VYNE (Vyne Therapeutics) with a proven track record?
Which analyst has the current lower performing score on VYNE (Vyne Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VYNE (Vyne Therapeutics)?
Which analyst is the currently most bullish on VYNE (Vyne Therapeutics)?
Which analyst is the currently most reserved on VYNE (Vyne Therapeutics)?
